ASSOCIATION OF PROSTATE CANCER GENETIC RISK ALLELES WITH PROSTATE BIOPSY RESULTSBrachial ArteryEndothelial DysfunctionErectile DysfunctionPhosphodiesterase InhibitorsPolyarteritis NodosaSildenafilTestisAlthough management of warfarin is challenging for patients with chronic kidney disease (CKD), no prospective studies ...
Loeb S. Prostate cancer: predicting prostate biopsy results-PCA3 versus phi. Nat Rev Urol 2015;12:130-1.Loeb S.Prostate cancer:Predicting prostate biopsy results--PCA3versus phi[J].Nat Rev Urol,2015,12(3):130-131.Loeb S. Prostate cancer: Predicting prostate biopsy results- PCA3 versus phi...
The ZERO Prostate Cancer Support Community connects patients, families, friends and caregivers to enhance the quality of life for all those affected by prostate cancer. This community is sponsored by ZERO Prostate Cancer, an Inspire trusted partner.
being tested for prostate cancer overall. For example: ‘I tried not to think about the PSA blood test’ (time-point 1); ‘I tried not to think about going for my biopsy’ (time-point 2); ‘I tried not to think about getting my biopsy results’ (time-point 3) and ‘I tried not...
Before the biopsy was performed, ablood testwas taken along withclinical datapertinent to the Stockholm3 test, which was conducted blinded to the biopsy results. Halving the number of unnecessary biopsies The analysis shows that clinically relevantprostate cancercases were found in a total of 29% ...
Prostate cancer is a complex disease that affects millions of men globally, predominantly in high human development index regions. Patients with localized disease at a low to intermediate risk of recurrence generally have a favourable outcome of 99% over
A research team from Massachusetts General Hospital have established a significant correlation between PSA velocity and citrate concentration in the histo-benign tissue of prostate glands harboring tumors, suggesting that citrate levels could help to predict prostate cancer growth rates. Zinc accumulates in...
From an MRI System that improves lesion conspicuity, a biopsy device receives FDA clearance and an App that tracks stent implants. ASCO endorses prostate Ca active surveillance guideline March 2nd 2016 Surveillance “should be more commonly used for patients with low-risk prostate cancer,” argues...
et al. Frequency of propionibacterium acnes infection in prostate glands with negative biopsy results is an independent risk factor for prostate cancer in patients with increased serum PSA titers. PLoS ONE 12, e0169984 (2017). Article PubMed PubMed Central CAS Google Scholar De Marzo, A. M....
Additionally, for patients with negative biopsy results, mpMRI can enhance prostate cancer detection rates and underscore the importance of Active Surveillance (AS) protocols3,4. To standardize and optimize the diagnosis of prostate lesions using mpMRI, PI-RADS was developed to aid in the ...